BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 16673389)

  • 1. Controlled release of fibroblast growth factor-2 from an injectable 6-O-desulfated heparin hydrogel and subsequent effect on in vivo vascularization.
    Nakamura S; Ishihara M; Obara K; Masuoka K; Ishizuka T; Kanatani Y; Takase B; Matsui T; Hattori H; Sato T; Kariya Y; Maehara T
    J Biomed Mater Res A; 2006 Aug; 78(2):364-71. PubMed ID: 16673389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled release of fibroblast growth factors and heparin from photocrosslinked chitosan hydrogels and subsequent effect on in vivo vascularization.
    Ishihara M; Obara K; Ishizuka T; Fujita M; Sato M; Masuoka K; Saito Y; Yura H; Matsui T; Hattori H; Kikuchi M; Kurita A
    J Biomed Mater Res A; 2003 Mar; 64(3):551-9. PubMed ID: 12579570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of controlled release of fibroblast growth factor-2 from chitosan/fucoidan micro complex-hydrogel on in vitro and in vivo vascularization.
    Nakamura S; Nambu M; Ishizuka T; Hattori H; Kanatani Y; Takase B; Kishimoto S; Amano Y; Aoki H; Kiyosawa T; Ishihara M; Maehara T
    J Biomed Mater Res A; 2008 Jun; 85(3):619-27. PubMed ID: 17806115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic angiogenesis induced by controlled release of fibroblast growth factor-2 from injectable chitosan/non-anticoagulant heparin hydrogel in a rat hindlimb ischemia model.
    Fujita M; Ishihara M; Shimizu M; Obara K; Nakamura S; Kanatani Y; Morimoto Y; Takase B; Matsui T; Kikuchi M; Maehara T
    Wound Repair Regen; 2007; 15(1):58-65. PubMed ID: 17244320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor.
    Cai S; Liu Y; Zheng Shu X; Prestwich GD
    Biomaterials; 2005 Oct; 26(30):6054-67. PubMed ID: 15958243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled release of FGF-2 using fragmin/protamine microparticles and effect on neovascularization.
    Nakamura S; Kanatani Y; Kishimoto S; Nakamura S; Ohno C; Horio T; Masanori F; Hattori H; Tanaka Y; Kiyosawa T; Maehara T; Ishihara M
    J Biomed Mater Res A; 2009 Dec; 91(3):814-23. PubMed ID: 19051304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascularization in vivo caused by the controlled release of fibroblast growth factor-2 from an injectable chitosan/non-anticoagulant heparin hydrogel.
    Fujita M; Ishihara M; Simizu M; Obara K; Ishizuka T; Saito Y; Yura H; Morimoto Y; Takase B; Matsui T; Kikuchi M; Maehara T
    Biomaterials; 2004 Feb; 25(4):699-706. PubMed ID: 14607508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled release of paclitaxel from photocrosslinked chitosan hydrogels and its subsequent effect on subcutaneous tumor growth in mice.
    Obara K; Ishihara M; Ozeki Y; Ishizuka T; Hayashi T; Nakamura S; Saito Y; Yura H; Matsui T; Hattori H; Takase B; Ishihara M; Kikuchi M; Maehara T
    J Control Release; 2005 Dec; 110(1):79-89. PubMed ID: 16289419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interaction of chitosan with fibroblast growth factor-2 and its protection from inactivation.
    Masuoka K; Ishihara M; Asazuma T; Hattori H; Matsui T; Takase B; Kanatani Y; Fujita M; Saito Y; Yura H; Fujikawa K; Nemoto K
    Biomaterials; 2005 Jun; 26(16):3277-84. PubMed ID: 15603823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photo-crosslinkable and biodegradable Pluronic/heparin hydrogels for local and sustained delivery of angiogenic growth factor.
    Yoon JJ; Chung HJ; Park TG
    J Biomed Mater Res A; 2007 Dec; 83(3):597-605. PubMed ID: 17503533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled releases of FGF-2 and paclitaxel from chitosan hydrogels and their subsequent effects on wound repair, angiogenesis, and tumor growth.
    Ishihara M; Fujita M; Obara K; Hattori H; Nakamura S; Nambu M; Kiyosawa T; Kanatani Y; Takase B; Kikuchi M; Maehara T
    Curr Drug Deliv; 2006 Oct; 3(4):351-8. PubMed ID: 17076636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chitosan hydrogel as a drug delivery carrier to control angiogenesis.
    Ishihara M; Obara K; Nakamura S; Fujita M; Masuoka K; Kanatani Y; Takase B; Hattori H; Morimoto Y; Ishihara M; Maehara T; Kikuchi M
    J Artif Organs; 2006; 9(1):8-16. PubMed ID: 16614797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced angiogenesis through controlled release of basic fibroblast growth factor from peptide amphiphile for tissue regeneration.
    Hosseinkhani H; Hosseinkhani M; Khademhosseini A; Kobayashi H; Tabata Y
    Biomaterials; 2006 Dec; 27(34):5836-44. PubMed ID: 16930687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin-regulated release of growth factors in vitro and angiogenic response in vivo to implanted hyaluronan hydrogels containing VEGF and bFGF.
    Pike DB; Cai S; Pomraning KR; Firpo MA; Fisher RJ; Shu XZ; Prestwich GD; Peattie RA
    Biomaterials; 2006 Oct; 27(30):5242-51. PubMed ID: 16806456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of photocrosslinkable chitosan hydrogel containing fibroblast growth factor-2 in a rabbit model of chronic myocardial infarction.
    Fujita M; Ishihara M; Morimoto Y; Simizu M; Saito Y; Yura H; Matsui T; Takase B; Hattori H; Kanatani Y; Kikuchi M; Maehara T
    J Surg Res; 2005 Jun; 126(1):27-33. PubMed ID: 15916971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acceleration of wound healing in healing-impaired db/db mice with a photocrosslinkable chitosan hydrogel containing fibroblast growth factor-2.
    Obara K; Ishihara M; Fujita M; Kanatani Y; Hattori H; Matsui T; Takase B; Ozeki Y; Nakamura S; Ishizuka T; Tominaga S; Hiroi S; Kawai T; Maehara T
    Wound Repair Regen; 2005; 13(4):390-7. PubMed ID: 16008728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained release of vascular endothelial growth factor from calcium-induced alginate hydrogels reinforced by heparin and chitosan.
    Lee KW; Yoon JJ; Lee JH; Kim SY; Jung HJ; Kim SJ; Joh JW; Lee HH; Lee DS; Lee SK
    Transplant Proc; 2004 Oct; 36(8):2464-5. PubMed ID: 15561282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-delivery of FGF-2 and G-CSF from gelatin-based hydrogels as angiogenic therapy in a murine critical limb ischemic model.
    Layman H; Sacasa M; Murphy AE; Murphy AM; Pham SM; Andreopoulos FM
    Acta Biomater; 2009 Jan; 5(1):230-9. PubMed ID: 18713669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Periurethral injection of sustained release basic fibroblast growth factor improves sphincteric contractility of the rat urethra denervated by botulinum-a toxin.
    Takahashi S; Chen Q; Ogushi T; Fujimura T; Kumagai J; Matsumoto S; Hijikata S; Tabata Y; Kitamura T
    J Urol; 2006 Aug; 176(2):819-23. PubMed ID: 16813954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formation of dentinal bridge on surface of regenerated dental pulp in dentin defects by controlled release of fibroblast growth factor-2 from gelatin hydrogels.
    Ishimatsu H; Kitamura C; Morotomi T; Tabata Y; Nishihara T; Chen KK; Terashita M
    J Endod; 2009 Jun; 35(6):858-65. PubMed ID: 19482186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.